Activation of the MEK/ERK pathway by phosphorylation of threonine and tyrosine residues can quickly initiate ERK1/2-dependent biological processes in neurological diseases, including epilepsy and status epilepticus [39]. This evidence concerns the gene MAP2K7 and epilepsy.